These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26611551)

  • 1. Corticosteroids in Lupus Nephritis and Central Nervous System Lupus.
    Kamen DL; Zollars ES
    Rheum Dis Clin North Am; 2016 Feb; 42(1):63-73, viii. PubMed ID: 26611551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus complicated with pulmonary hemorrhage in a 17-year-old female.
    Vijatov-Djuric G; Stojanovic V; Tomic J; Konstantinidis N; Konstantinidis G
    Lupus; 2010 Nov; 19(13):1561-4. PubMed ID: 20682580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
    Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
    Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus].
    Kneitz C; Goebeler M; Tony HP
    Internist (Berl); 2003 Dec; 44(12):1557-71; quiz 1572-3. PubMed ID: 15132164
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic management of neuropsychiatric lupus.
    Kivity S; Baker B; Arango MT; Chapman J; Shoenfeld Y
    Expert Rev Clin Pharmacol; 2016; 9(1):103-8. PubMed ID: 26559084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in treatment of systemic lupus erythematosus].
    Wang Q; Zhang X
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):161-4. PubMed ID: 23751573
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we manage lupus nephritis without chronic corticosteroids administration?
    Lightstone L; Doria A; Wilson H; Ward FL; Larosa M; Bargman JM
    Autoimmun Rev; 2018 Jan; 17(1):4-10. PubMed ID: 29108828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of cyclophosphamide in the treatment of severe systemic lupus erythematosus.
    Glisic B; Popovic M; Popovic R; Mitrovic D; Stefanovic D; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2300-1. PubMed ID: 11377536
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system lupus: a clinical approach to therapy.
    Sanna G; Bertolaccini ML; Mathieu A
    Lupus; 2003; 12(12):935-42. PubMed ID: 14714914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of patient survival in systemic lupus erythematosus--focusing on lupus nephritis.
    Chan TM
    Ethn Dis; 2006; 16(2 Suppl 2):S2-66-9. PubMed ID: 16774014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus.
    Lilleby V; Flatø B; Førre O
    Clin Exp Rheumatol; 2005; 23(2):261-9. PubMed ID: 15895902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids combined with doublet or single-agent immunosuppressive therapy for active proliferative lupus nephritis.
    Liu B; Ou Q; Tang Y; Fu S; Liang P; Yu Y; Xu Z; Chen Y; Xu A
    Clin Rheumatol; 2019 Sep; 38(9):2519-2528. PubMed ID: 31081535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission and withdrawal of therapy in lupus nephritis.
    Moroni G; Raffiotta F; Ponticelli C
    J Nephrol; 2016 Aug; 29(4):559-65. PubMed ID: 27146861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
    Boumpas DT; Sidiropoulos P; Bertsias G
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening extrarenal lupus in children despite improvement in serologic findings.
    Butani L; Makker SP
    Rheumatol Int; 2003 Mar; 23(2):92-5. PubMed ID: 12634943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
    Hoover PJ; Costenbader KH
    Kidney Int; 2016 Sep; 90(3):487-92. PubMed ID: 27344205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus.
    Couture J; Silverman ED
    Curr Opin Rheumatol; 2016 Sep; 28(5):488-96. PubMed ID: 27341622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric lupus nephritis: more options, more chances?
    Vachvanichsanong P; McNeil E
    Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.